Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Unaudited)

v3.23.2
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2021 $ 117,956   $ 230,543   $ (112,587)
Beginning balance, Shares at Dec. 31, 2021   28,927,129      
Stock-based compensation 1,811   1,811    
Net unrealized losses on available-for-sale securities (152)     $ (152)  
Issuance of common stock in connection with exercise of stock options 51   51    
Issuance of common stock in connection with exercise of stock options, Shares   50,000      
Net Income (Loss) (12,946)       (12,946)
Ending balance at Mar. 31, 2022 106,720   232,405 (152) (125,533)
Ending balance, Shares at Mar. 31, 2022   28,977,129      
Beginning balance at Dec. 31, 2021 117,956   230,543   (112,587)
Beginning balance, Shares at Dec. 31, 2021   28,927,129      
Net Income (Loss) (25,856)        
Ending balance at Jun. 30, 2022 95,530   234,222 (249) (138,443)
Ending balance, Shares at Jun. 30, 2022   29,013,995      
Beginning balance at Mar. 31, 2022 106,720   232,405 (152) (125,533)
Beginning balance, Shares at Mar. 31, 2022   28,977,129      
Stock-based compensation 1,777   1,777    
Net unrealized losses on available-for-sale securities (97)     (97)  
Issuance of common stock under employee stock purchase plan 40   40    
Issuance of common stock under employee stock purchase plan, Shares   36,866      
Net Income (Loss) (12,910)       (12,910)
Ending balance at Jun. 30, 2022 95,530   234,222 (249) (138,443)
Ending balance, Shares at Jun. 30, 2022   29,013,995      
Beginning balance at Dec. 31, 2022 $ 104,520   270,129 (47) (165,562)
Beginning balance, Shares at Dec. 31, 2022 29,445,134 29,445,134      
Stock-based compensation $ 2,480   2,480    
Net unrealized losses on available-for-sale securities 47     47  
Issuance of common stock in connection with exercise of stock options 458   458    
Issuance of common stock in connection with exercise of stock options, Shares   84,264      
Issuance of common stock upon exercise of pre-funded warrants   1,811,591      
Net Income (Loss) (15,854)       (15,854)
Ending balance at Mar. 31, 2023 91,651   273,067   (181,416)
Ending balance, Shares at Mar. 31, 2023   31,340,989      
Beginning balance at Dec. 31, 2022 $ 104,520   270,129 (47) (165,562)
Beginning balance, Shares at Dec. 31, 2022 29,445,134 29,445,134      
Net Income (Loss) $ (30,341)        
Ending balance at Jun. 30, 2023 $ 174,141   370,047 (3) (195,903)
Ending balance, Shares at Jun. 30, 2023 39,793,682 39,793,682      
Beginning balance at Mar. 31, 2023 $ 91,651   273,067   (181,416)
Beginning balance, Shares at Mar. 31, 2023   31,340,989      
Stock-based compensation 2,803   2,803    
Common stock issuance 93,755   93,755    
Common stock issuance, Shares   8,337,500      
Net unrealized losses on available-for-sale securities (3)     (3)  
Issuance of common stock in connection with exercise of stock options 390   390    
Issuance of common stock in connection with exercise of stock options, Shares   107,122      
Issuance of common stock under employee stock purchase plan 32   32    
Issuance of common stock under employee stock purchase plan, Shares   8,071      
Net Income (Loss) (14,487)       (14,487)
Ending balance at Jun. 30, 2023 $ 174,141   $ 370,047 $ (3) $ (195,903)
Ending balance, Shares at Jun. 30, 2023 39,793,682 39,793,682